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Abstract  17 
 Dysgeusia (abnormal taste) is common in those with chronic kidney disease and 18 
contributes to poor nutritional intake. Previous sensory work has shown that taste improves 19 
after dialysis sessions. The goal of this pilot study was to characterize altered taste perceptions 20 
in patients on dialysis compared to healthy adults, and to evaluate relationships between 21 
serum parameters with taste perceptions. We hypothesized that patients undergoing dialysis 22 
would experience blunted taste intensities compared to controls, and that serum levels of 23 
potential tastants would be inversely related to taste perception of compounds. Using a cross-24 
sectional design, we carried out supra-threshold sensory assessments (flavor intensity and 25 
liking) of tastants/flavors potentially influenced by kidney disease and/or the dialysis 26 
procedure. These included sodium chloride, potassium chloride, calcium chloride, sodium 27 
phosphate, phosphoric acid, urea, ferrous sulfate and monosodium glutamate. Individuals on 28 
maintenance hemodialysis (n= 17, 10 males, range 23-87 years) were compared to controls 29 
with normal gustatory function (n=29, 13 males, range 21-61 years). Unadjusted values for 30 
intensity and liking for the solutions showed minimal differences. However, when values were 31 
adjusted for participants’ perceptions of water (as a control for taste abnormalities), intensity 32 
of monosodium glutamate, sodium chloride, and sodium phosphate solutions were more 33 
intense for patients on dialysis compared to controls. Some significant correlations were also 34 
observed between serum parameters, particularly potassium, for dialysis patients and sensory 35 
ratings. These results suggest altered taste perception in patients during dialysis warrants 36 
further study.  37 
Keywords: Chronic kidney disease, dysgeusia, hemodialysis, taste 38 
 39 
Introduction  40 
 Chronic kidney disease (CKD) affects approximately 11-13% of the worldwide 41 
population (Hill, Fatoba et al. 2016). Progression of the disease can often warrant the 42 
commencement of dialysis, with hemodialysis being the most common modality of renal 43 
replacement therapy. Patients receiving dialysis are subject to prescriptive diets (Kalantar-Zadeh, 44 
Tortorici et al. 2015), which can help increase dialysis effectiveness by improving parameters 45 
such as serum electrolytes, acid-base balance, and blood pressure (Mc Causland, Waikar et al. 46 
2012, Beerendrakumar and Haridasan 2018). Despite the multitude of benefits attributed to these 47 
prescribed diets, poor dietary adherence is still a major issue, as recent systematic review 48 
(Oquendo, Asencio et al. 2017) noted that 25% to 86% of hemodialysis patients do not adhere to 49 
these diets. This can predispose patients to a higher risk of malnutrition and hence, poorer 50 
survival outcomes and quality of life (Boltong and Campbell 2013, Lynch, Lynch et al. 2013).  51 
One explanation for this poor adherence is dysgeusia, abnormal taste sensation, which 52 
affects approximately 35% of end-stage renal disease patients (Lynch, Lynch et al. 2013). Some 53 
commonly noted taste disturbances include reduced taste acuity, impaired detection of salty taste 54 
and reporting that certain foods taste ‘metallic-like’ (Boltong and Campbell 2013, McMahon, 55 
Campbell et al. 2014). Abnormalities in taste sensation may adversely affect the palatability of 56 
food and thus decrease adherence to renal diets.  57 
 Fluid imbalances, uremic toxin accumulation, metabolic derangements and zinc 58 
deficiency are some hypothesized mechanisms linked with the onset of dysgeusia (Carrero 2011, 59 
Boltong and Campbell 2013, Lynch, Lynch et al. 2013, Neto, Bacci et al. 2016). Specific to 60 
CKD patients, imbalances in ions, uremic toxins, or other small compounds in blood could be 61 
contributing to altered vascular and salivary concentrations of solutes (Manley, Haryono et al. 62 
2012). This may alter the baseline at which oral chemoreceptor cells are responding to stimuli in 63 
foods. Vascular taste is when taste cells respond to tastants in the blood from the basolateral side 64 
of the receptor cell; as CKD patients have altered dynamics and levels of various taste active 65 
stimuli in blood (e.g., sodium, potassium, urea, etc.), vascular taste could be altered in these 66 
individuals. Further, oral chemosensation could also be altered through salivary changes, as prior 67 
research has shown that CKD patients have altered salivary composition of several compounds 68 
that are active chemosensory stimuli in foods, including calcium, potassium and urea (Manley, 69 
Haryono et al. 2012, Seethalakshmi, Koteeswaran et al. 2014, Rodrigues and Franco 2015). This 70 
may be escalated by specific taste genetics that are sensitive to the increased salivary urea often 71 
found in this particular patient group (Manley 2015). Additionally, previous studies have implied 72 
that salivary and serum concentrations of these compounds are correlated and that taste 73 
sensations improve following dialysis sessions (Burge, Park et al. 1979, Shepherd, Farleigh et al. 74 
1986, Farleigh, Shepherd et al. 1987, Seethalakshmi, Koteeswaran et al. 2014, Rodrigues and 75 
Franco 2015). Hence, alterations in saliva or vascular taste due to serum abnormalities may play 76 
a mechanistic role in these altered taste perceptions.  77 
 Previous studies have examined this hypothesis for five primary tastes: sweet, salty, 78 
bitter, sour, and umami (Burge, Park et al. 1979, Shepherd, Farleigh et al. 1986, Farleigh, 79 
Shepherd et al. 1987, Manley, Haryono et al. 2012, McMahon, Campbell et al. 2014). However, 80 
other salts and small molecules are also chemosensory stimuli, and the differences among these 81 
less prototypical “tastants” has not been evaluated. Thus, this pilot study aimed to test how 82 
hemodialysis patients perceive a wider range of chemosensory stimuli, specifically focusing on 83 
ions and other small molecules that are likely to be altered in serum for CKD patients compared 84 
to healthy controls.  85 
 86 
Materials and Methods  87 
Study Design 88 
 This pilot study used a cross-sectional design to compare perception of taste-active 89 
compounds in dialysis patients (n=17) versus a control group (n=29). A sensory assessment was 90 
conducted in which participants provided feedback on flavor intensity and liking/disliking for a 91 
variety of stimuli that may be present at abnormal concentrations in the blood and/or saliva of 92 
patients undergoing dialysis.  93 
 94 
Participants  95 
 The target population for this study was adult patients with end-stage renal disease 96 
attending a local dialysis clinic in Lafayette, IN for thrice weekly maintenance hemodialysis 97 
(n=17). All participants were invited to take part in the study during their normal scheduled 98 
dialysis treatment session. Control subjects (n=29) were recruited through the Purdue University 99 
Sensory Perception Ingestion and Tongues (SPIT) Laboratory participant pool. Inclusion criteria 100 
for the control subjects included: self-reported normal gustatory function, no issues with 101 
salivation or dry mouth; 18 years of age or older; and no tongue, lip, or cheek piercings. All 102 
participants gave written informed consent prior to participating in this study. The protocol was 103 
approved by the Human Subjects Institutional Review Board of Purdue University and registered 104 
at www.clinicaltrials.gov (NCT03495271).    105 
 106 
Tasting Solutions 107 
 Solutions are listed in Table 1.  All chemicals were food grade, and all were purchased 108 
from Sigma-Aldrich with the exception of calcium chloride (Modernist Pantry, USA); and 109 
monosodium glutamate (Ajinomoto, Japan). The solutions were presented to subjects in 15 mL 110 
aliquots at room temperature.  All solutions were prepared on the day before each testing.  111 
 112 
Tasting Protocol 113 
 Each solution was presented at room temperature to participants in a blinded fashion and 114 
in counterbalanced order. We aimed to carry out the dialysis taste assessments at the beginning 115 
of the patient’s dialysis session, but this was not always consistent due to the clinic set-up.  116 
 117 
As these stimuli are generally unpleasant, all participants tasted a urea and potassium 118 
chloride sample first to control for bias as a result of the initial exposure to the unpleasant 119 
sensation  (termed “first sample effect” in the sensory field, or “initial elevation bias” in 120 
psychology (Shrout, Stadler et al. 2018). Participants tasted 15 ml aliquots of each sample and 121 
expectorated after 10 seconds. After tasting each solution, participants reported perceived flavor 122 
intensity and liking/disliking of the solution. Participants rinsed their mouths with spring water 123 
(Ice Mountain brand bottled water) between each sample.  124 
 125 
Sensory Questionnaire 126 
  Sensory questions were asked verbally by experimenters and data were recorded using 127 
RedJade sensory software. For each sample, the experimenter asked the participant to rate the 128 
overall flavor intensity of the solution on a scale from 0 – 100, with 0 being no sensation and 100 129 
being the strongest sensation ever experienced. Participants were familiarized with this intensity 130 
scale using a warm-up questionnaire, which asked about the brightness of this room, the 131 
brightness of the sun, the loudness of a shout, the loudness of a whisper, the bitterness of black 132 
coffee, and the sweetness of pure sugar (adapted from (Hayes, Allen et al. 2013)). For the 133 
samples, participants also reported their liking for the sensation, with 0 being the “worst thing 134 
ever” and 100 being the “best thing ever”.   135 
 136 
 137 
Blood Sample Collections 138 
 Non-fasting serum blood samples (8mL) were drawn from dialysis access following taste 139 
assessments and analyzed by Mid America Clinical Laboratories. Samples were targeted to be 140 
collected within 30 minutes of the taste assessment, but this varied considerably from subject to 141 
subject due to the active clinic environment.  142 
 143 
Statistical Analysis 144 
 Data were analyzed using SAS for Windows, version 9.4 (Cary, North Carolina, USA).  145 
Significant differences between the variables were assessed using mixed models controlling for 146 
year of birth, sex, order effects, and subjects (as a repeated measure); the Kenward Roger method 147 
was applied for calculation of degrees of freedom. The dependent variables were flavor intensity 148 
or liking/disliking rating, and the variables of interest were the sample type, group (control or 149 
dialysis), and the interaction of group and sample type. Statistical code is available in 150 
supplemental files. Sensory ratings were analyzed both as unadjusted as well as adjusted for each 151 
participant’s perception of water (Water adjusted rating = Original rating – water rating). This 152 
approach controlled for between-subject variability in how they used the scale, but also 153 
controlled for baseline abnormalities in perception of water. Water is not a neutral stimulus, and 154 
different sources of water can lead to changes in perception of flavor intensity and/or sensitivity 155 
to tastes (Dalton, Nagata et al. 2000, Hoehl, Schoenberger et al. 2010). Deionized water, which 156 
was the solvent in this study, is often described as bitter or metallic, perhaps because the pH is 157 
actually below neutral (Whelton, Dietrich et al. 2007).  Subtracting the rating of the water from 158 
the rating of the tastant solutions thus gives a better idea of how individual participants perceived 159 
the solutes in contrast to a standard (deionized water) with minimal solutes.  Thus, the water-160 
adjusted ratings were calculated for each individuals’ intensity and liking ratings for every test 161 
solution. Alpha was set at 0.05 across all tests. Spearman correlations were used to identify 162 
possible relationships between serum parameters and taste perceptions in the dialysis patients. 163 
 164 
Results  165 
Baseline Characteristics of the Study Population 166 
 Participant characteristics are reported in Table 2. The control group was significantly 167 
younger than the dialysis group (P<0.001). Baseline taste abnormalities were reported by 43.8% 168 
of the dialysis cohort. Abnormal sensations reported included that “everything tastes bitter/sour”, 169 
“some fruits don’t taste as sweet”, “higher salt threshold”, and “metallic tastes.” 170 
Flavor Intensity 171 
Unadjusted flavor intensity values are presented in Figure 1 and showed no differences 172 
(p=0.73) between groups overall, only trends in effects for interactions within sample types. 173 
After adjustment for deionized water taste, significant differences emerged (Figure 2, p=0.044 174 
between groups). Specifically, water-corrected ratings for monosodium glutamate (p=0.0016), 175 
sodium chloride (p=0.0018), and sodium phosphate (p=0.017) were higher for dialysis patients 176 
compared to control participants.  177 
 178 
Hedonic ratings 179 
Liking/disliking values are presented in Figure 3 & 4. Unadjusted liking scores (Figure 180 
3) highlights general, and similar (p=0.37 between groups, no significant interactions) disliking 181 
for the solutions across both groups, which is signified by a mean score of <50 (i.e. values were 182 
closer to ‘worst ever’ side of the scale). Adjusted liking data is shown in Figure 4, and are more 183 
negative due to more dislike for the flavors versus water. The dialysis group’s adjusted liking 184 
ratings were less negative than the control group’s, indicating the patients on dialysis rated the 185 
samples closer to water for liking than controls (p=0.023), which could indicate the dialysis 186 
group actually found the solutions closer to hedonically neutral than the control group. Specific 187 
samples driving this difference between the groups were ferrous sulfate (p= 0.0092), potassium 188 
chloride (p=0.014), sodium chloride (p=0.045), and sodium phosphate (p=0.042);  189 
 190 
Serum parameters and taste  191 
 Serum results for the patients on dialysis are reported in Table 3, and significant 192 
correlations are shown in Table 4. One sample was excluded due to hemolysis. Spearman 193 
correlations were conducted between the sensory ratings and serum levels of compounds of 194 
interest. In unadjusted ratings, a negative correlation was observed between serum glucose and 195 
urea flavor intensity (p= 0.035); negative correlations for unadjusted liking ratings were also 196 
observed between flavor intensity of monosodium glutamate and creatinine (p= 0.033). In water 197 
adjusted ratings, a positive correlation was observed between serum potassium and taste intensity 198 
of monosodium glutamate (p= 0.019); in adjusted liking ratings, positive correlations were 199 
observed between serum potassium and phosphoric acid (p= 0.0008), potassium chloride ((p= 200 
0.027), urea (p= 0.028), and calcium chloride (p= 0.028). Negative correlations were observed 201 
between adjusted liking ratings for urea and serum carbon dioxide (p= 0.038) and between 202 
ferrous sulfate and serum sodium (p= 0.045).   203 
 204 
Discussion 205 
 In the present pilot study, we found water-adjusted flavor and liking intensity scores were 206 
different between control and dialysis patients. Specifically, dialysis patients reported a more 207 
intense sensation for two sodium containing salts (monosodium glutamate, sodium chloride) and 208 
a less intense sensation for one compound, another sodium containing salt (sodium phosphate). 209 
Differences in adjusted liking ratings appear to be primarily due to ferrous sulfate, potassium 210 
chloride, sodium chloride, and sodium phosphate being rated closer to water ratings (near neutral 211 
on the hedonic scale) for the dialysis group compared to control. The differences found in the 212 
water-adjusted data, but not unadjusted data, suggest that baseline taste perception may be an 213 
important factor for dysgeusia in dialysis patients and should be better characterized in future 214 
studies.   215 
 Prior studies have generally shown that patients with CKD often experience lower taste 216 
intensity and/or sensitivity for sodium containing compounds, along with other tastants. One 217 
study (Manley, Haryono et al. 2012) conducted suggested that CKD patients have an impaired 218 
ability to identify sour, bitter and glutamate tastes. Another study (McMahon, Campbell et al. 219 
2014) also reported significantly lower intensity scores for monosodium glutamate and sodium 220 
chloride. In that particular study, higher salivary and serum sodium levels correlated with lower 221 
sensitivity to tasting sodium (McMahon, Campbell et al. 2014). A possible explanation for 222 
differences between these reports and our current work is that our taste assessments were not 223 
performed in the dialysis patients until they had undergone some of their dialysis treatment. 224 
Although we aimed to complete the assessment at the beginning of treatment, this was not 225 
feasible due to the busy clinical setting, and on occasion was not conducted until >30minutes 226 
after dialysis commencement. It is possible that excess salivary and serum sodium was filtered 227 
through the dialysate, reducing their sodium taste-threshold and improving sensitivity. Indeed, 228 
previous research has shown that dialysis treatment removes excess salivary metabolites in a 229 
mirror-like fashion to serum filtration (Seethalakshmi, Koteeswaran et al. 2014, Khanum, 230 
Mysore-Shivalingu et al. 2017). In addition, this has been linked to improved taste function post-231 
dialysis (Burge, Park et al. 1979). Older studies have indicated increased sensitivity and 232 
decreased preference for sodium chloride post dialysis which may further explain the higher 233 
ratings noted in our dialysis group by comparison to healthy controls (Farleigh, Shepherd, et al. 234 
1987, Shepherd, Farleigh et al. 1987, Leshem & Rudoy 1997) . Furthermore, given the difference 235 
in our findings between water-adjusted and unadjusted assessments, and the lack of major 236 
correlations with serum levels for sodium, it is possible that baseline abnormalities in taste are 237 
more important than acute changes during dialysis.   238 
 In our study, unadjusted liking scores were generally rated <50 on the scales in both 239 
patients and controls which indicated overall negative hedonic reaction to the solutions. These 240 
lower ratings were expected given that the solutions were characteristically unpalatable, with 241 
some leaving lingering tastes (e.g. ferrous sulfate and monosodium glutamate, in particular). 242 
However, food ingredients lead to very different affective responses when presented in foods 243 
versus in solution. Monosodium glutamate, for example, can make a variety of foods more 244 
palatable, but is generally unpleasant when tasted in isolation. Patients undergoing dialysis 245 
indicated that sodium phosphate, sodium chloride, potassium chloride, and ferrous sulfate 246 
solutions tasted closer to a “neutral” water their control counterparts. However, distractions from 247 
the dialysis procedure itself may have influenced these ratings. In general, we would expect the 248 
busy clinical environment of a dialysis unit to confound liking ratings.  However, we would have 249 
expected the negative feelings of the environment (due to having to go through the process of 250 
dialysis) could leech into negative affect for the stimuli presented. This was not the case.  Future 251 
studies should be conducted in a better controlled environment, or with controls in a similar 252 
clinical environment to the patients attending dialysis.   253 
 254 
 We detected few associations between serum parameters and hemodialysis patient’s 255 
flavor ratings in the present study. We did however observe that serum potassium, in particular, 256 
correlated with water-adjusted hedonic ratings for a number of compounds. This may imply a 257 
role for potassium in the hedonic perception of other flavors. As several potassium channels are 258 
proposed to influence different types of taste (particularly sour and fatty tastes (Gilbertson, 259 
Fontenot et al. 1997, Challis and Ma 2016)), imbalances in potassium may alter taste cell 260 
signaling, resulting in abnormalities in the quality of sensations and changes in effect. This 261 
should be pursued in further work, both in patients on dialysis as well as healthy controls.  262 
Prior research indicates that taste thresholds of renal patients increase with age and this finding is 263 
also in agreement with results of studies on healthy subjects (Ogawa, Annear et al. 2017, Ng, 264 
Woo et al. 2004, Vreman, Venter et al. 1980, Ciechanover, Peresecenschi et al. 1980). Therefore, 265 
it is important to consider the fact that our dialysis and control groups were not demographically 266 
well matched, especially in terms of age. Age was included as a covariate in our statistical model 267 
and indeed indicated that younger subjects had higher ratings, even when adjusted for water. 268 
This is consistent with other work. However, our patients on dialysis actually gave higher ratings 269 
than the younger controls, which is directly the opposite of what we would expect for an age 270 
effect, and indeed is also opposite from what we saw in our own model’s age effect Certainly, 271 
matching the groups for age could improve our understanding of these potential differences 272 
between groups, but a multitude of other confounding variables  may also impact on our ability 273 
to conduct taste tests in renal patients. Medications, diet and other chronic diseases can play an 274 
influential role on taste perception, each of which are difficult to control for, especially in older 275 
subjects who have many health issues (Boltong and Campbell 2013).  276 
 There are several other limitations to this study which must also be considered.  As a 277 
pilot study, the sample size was small and thus results should be considered preliminary. 278 
Secondly, the control group did not have serum parameters measured for comparison. 279 
Furthermore, our ability to assess the serum-taste perception relationship was restrained 280 
considering our serum samples were drawn late into the dialysis session. Future larger studies 281 
should be pursued using controlled, or at least comparable, environments and protocols to 282 
minimize confounding factors in our clinical setting. 283 
Finally, our findings of greater differences when controlling for water perception should 284 
be further investigated. Deionized water itself stimulates sensation in the mouth, often of greater 285 
intensity than tap or spring waters (Hoehl, Schoenberger et al. 2010). We did not find a 286 
difference in taste intensity of deionized water between our groups in the current study, but this 287 
concept should be further investigated to determine if individual differences in serum and 288 
salivary solutes contribute to differences in perception of water, or some sort of partitioning of 289 
solutes within the deionized water, which could then alter perception of other dissolved solids. 290 
Our findings indicate that it may be important to correct for this baseline sensation of the solvent 291 
in future work to investigate dysgeusia in patients undergoing hemodialysis.  292 
 293 
Conclusion 294 
 The findings of this study add to the body of evidence suggesting that taste changes occur 295 
with CKD. Our work emphasizes the need to investigate taste and flavor active compounds 296 
beyond the prototypical taste stimuli for sweet, sour, salty, bitter and umami tastes. As many 297 
known tastants are found in human serum and saliva, and are dysregulated with CKD, these non-298 
typical stimuli are prime candidates for contributing to dysgeusia accompanying CKD. We 299 
identified CKD patients experienced altered taste intensity for compounds that include a sodium 300 
ion (greater intensity for monosodium glutamate and sodium chloride, and lesser intensity for 301 
sodium phosphate) and lesser dislike for ferrous sulfate, potassium chloride, sodium chloride, 302 
and sodium phosphate compared to healthy controls, when correcting for the subjects’ 303 
perceptions of deionized water. More research is required to fully evaluate how dysgeusia is 304 
experienced by CKD patients.  305 
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 Table 1: Concentration of Solutions used in the Taste Assessment 318 
Compounds Molarity (M)  %(w/w) Sensory quality 
Sodium Chloride 0.2 1.16 Salty 
Potassium Chloride 0.01 0.74 Salty, bitter 
Calcium Chloride 0.15 1.62 Calcium taste†, metallic 
Sodium Phosphate 0.0063 0.09 Salty, phosphorous taste† 
Phosphoric Acid 0.007 0.37 Sour 
Urea 0.5 2.91 Bitter 
Ferrous Sulfate 0.025 0.69 Metallic 
Monosodium Glutamate 0.01 0.17 Umami 
Deionised Water - - Control (solvent) 
†These “tastes” are under debate as potential gustatory sensations; we will refer to them 
as tastes for simplicity in this report, but readers should consult other articles to 
understand the state of the science regarding these compounds as taste stimuli (Tordoff, 
Alarcón et al. 2012, Tordoff 2017).  
 
 
Table 2: Participant Characteristics  319 
 Control  Dialysis 
N 29 17 
Gender     Male, N (%) 





Age (years) 32 (range 21-61) 61 (range 23-87)* 
Taste Abnormalities, N (%) - 7 (43.8) 







Table 3: Serum Parameters for Dialysis Patients 320 
Blood Parameters Ref. Range* Mean 
Magnesium (mg/dL) 1.6-2.6 2.04 ± 0.17 
Sodium (mmol/L) 136-145 137.60 ± 2.06 
Potassium (mmol/L) 3.5-5.1 4.31 ± 0.56 
Calcium (mg/dL) 8.4-10.5 8.91 ± 0.63 
Phosphorous (mg/dL) 2.5-4.7 3.37 ± 1.69 
Chloride (mmol/L) 98-110 98.93 ± 2.25 
Carbon dioxide (mmol/L) 20-29 24.27 ± 3.90 
Glucose (mg/dL) 65-99 128.07 ± 58.39 
Urea Nitrogen (mg/dL) 10-20 33.40 ± 17.14 
Creatinine (mg/dL) 0.70-1.20 5.24± 3.14 
Albumin (mg/dL) 3.5-5.0 3.57 ± .35 
* reference range provided by Mid America Clinical Laboratories.  
 
Table 4: Spearman correlations between sensory ratings and serum parameters 
Rating type Sensory stimulus Serum parameter Spearman Rho p-value 
Unadjusted flavor Urea Glucose -0.55 0.035 
Water adjusted flavor 
Monosodium 
glutamate 




Creatinine -0.55 0.033 
Water adjusted liking Phosphoric acid Potassium 0.77 0.0008 
 Potassium chloride Potassium 0.57 0.027 
 Urea Potassium 0.57 0.028 
 Calcium chloride Potassium 0.56 0.028 
 Urea Carbon dioxide -0.54 0.038 
 Ferrous sulfate Sodium -0.52 0.045 
 
 
  321 
 322 
 323 





Figure 2: Mean and standard error for flavor intensity after adjustment for the perception of 
water (Original rating – water rating; positive values indicate the sample was rated as more 
intense than water) 
 326 
 327 












































































































Figure 4: Mean and standard error for liking of compounds after adjustment for the perception 335 
of water (Original rating – water rating; negative numbers indicate water was liked more than 336 
the sample, and numbers to closer to zero mean the sample was rated more similarly to water). 337 
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Supplemental files 420 
 421 
 422 
proc sort data=CKD; 423 
by sample group cond id Order; 424 
run; 425 
ods graphics on; 426 
ods output tests3=mixedtestsFlavorV; 427 
ods output diffs=FVdiff; 428 
Title 'Flavor tests'; 429 
proc mixed data=ckd; 430 
class id Sample sex group order; 431 
model flavor =  sample group sex YOB sample*group/ residual outp=FTVresid 432 
ddfm=KR;  433 
repeated order/ subject=id type= ar(1); 434 
lsmeans group / pdiff  ADJDFE=ROW; 435 
lsmeans sample*group/ pdiff ADJDFE=ROW; 436 
run; 437 
quit; 438 
ods graphics off; 439 
 440 
 441 
proc sort data=CKD; 442 
by sample group cond id Order; 443 
run; 444 
ods graphics on; 445 
ods output tests3=mixedtestsLikingV; 446 
ods output diffs=LVdiff; 447 
Title 'Liking tests'; 448 
proc mixed data=ckd; 449 
class id Sample sex group order; 450 
model liking=  sample group sex YOB sample*group/ residual outp=LTVresid 451 
ddfm=KR;  452 
repeated order / subject=id type= ar(1); 453 
lsmeans group / pdiff ADJDFE=ROW; 454 
lsmeans sample*group/ pdiff  ADJDFE=ROW; 455 
run; 456 
quit; 457 
ods graphics off; 458 
 459 
 460 
proc sort data=CKD; 461 
by sample group cond id Order; 462 
run; 463 
ods graphics on; 464 
ods output tests3=mixedtestsFlavorVW; 465 
ods output diffs=FWVdiff; 466 
Title 'Flavor tests corrected for water'; 467 
proc mixed data=ckd; 468 
where sample ne 'Water'; 469 
class id Sample sex group order; 470 
model FlSam_H2O =  sample group sex YOB sample*group/ residual outp=FTVWresid 471 
ddfm=KR;  472 
repeated order/ subject=id type= ar(1); 473 
lsmeans group / pdiff ADJDFE=ROW; 474 
lsmeans sample*group/ pdiff ADJDFE=ROW; 475 
run; 476 
quit; 477 
ods graphics off; 478 
 479 
 480 
proc sort data=CKD; 481 
by sample group cond id Order; 482 
run; 483 
ods graphics on; 484 
ods output tests3=mixedtestsLikingVW; 485 
ods output diffs=LWVdiff; 486 
Title 'Liking tests Corrected for water'; 487 
proc mixed data=ckd; 488 
where sample ne 'Water'; 489 
class id Sample sex group order; 490 
model lSam_H2O=  sample group sex YOB sample*group/ residual outp=LTVWresid 491 
ddfm=KR;  492 
repeated order / subject=id type= ar(1); 493 
lsmeans group / pdiff ADJDFE=ROW; 494 
lsmeans sample*group/ pdiff ADJDFE=ROW; 495 
run; 496 
quit; 497 
ods graphics off; 498 
  499 




Least Squares Means 
Effect Sample Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control 50.5126 2.0603 100 24.52 <.0001 
Group   Dialysis 49.0696 2.9437 101 16.67 <.0001 
Sample*Group CaCl Control 81.9541 4.0147 432 20.41 <.0001 
Sample*Group CaCl Dialysis 81.2260 5.3834 420 15.09 <.0001 
Sample*Group FeSO4 Control 56.0913 4.0975 417 13.69 <.0001 
Sample*Group FeSO4 Dialysis 53.4420 5.4846 402 9.74 <.0001 
Sample*Group First Control 74.2222 4.0975 417 18.11 <.0001 
Sample*Group First Dialysis 47.2262 5.4847 402 8.61 <.0001 
Sample*Group H3PO4 Control 58.9556 4.0146 432 14.69 <.0001 
Sample*Group H3PO4 Dialysis 53.0668 5.3831 420 9.86 <.0001 
Sample*Group KCl Control 49.1579 4.0147 432 12.24 <.0001 
Sample*Group KCl Dialysis 47.6526 5.3796 421 8.86 <.0001 
Sample*Group MSG Control 32.2199 4.0125 433 8.03 <.0001 
Sample*Group MSG Dialysis 45.4563 5.3819 421 8.45 <.0001 
Sample*Group NaCl Control 58.7771 4.0147 432 14.64 <.0001 
Sample*Group NaCl Dialysis 70.9695 5.3767 422 13.20 <.0001 
Sample*Group NaPO4 Control 15.1123 4.0147 432 3.76 0.0002 
Sample*Group NaPO4 Dialysis 18.8517 5.3820 421 3.50 0.0005 
Sample*Group Urea Control 59.9295 4.0151 432 14.93 <.0001 
Sample*Group Urea Dialysis 53.8460 5.3721 423 10.02 <.0001 
Sample*Group Water Control 18.7061 4.0128 433 4.66 <.0001 
Sample*Group Water Dialysis 18.9590 5.3865 419 3.52 0.0005 
 503 
 504 
Type 3 Tests of Fixed Effects  
Effect Num DF Den DF F Value Pr > F Effect 
Sample 9 351 46.99 <.0001  
Group 1 101 0.12 0.7267  
Sex 1 104 6.40 0.0129 Female>male 
YOB 1 104 0.40 0.5298  




Differences of Least Squares Means 
Effect Sample Group _Sample _Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control   Dialysis 1.4430 4.1167 101 0.35 0.7267 
Sample*Group CaCl Control CaCl Dialysis 0.7281 7.0097 400 0.10 0.9173 
Sample*Group FeSO4 Control FeSO4 Dialysis 2.6493 7.1349 379 0.37 0.7106 
Sample*Group First Control First Dialysis 26.9960 7.1350 379 3.78 0.0002 
Sample*Group H3PO4 Control H3PO4 Dialysis 5.8888 7.0093 400 0.84 0.4013 
Sample*Group KCl Control KCl Dialysis 1.5053 7.0068 401 0.21 0.8300 
Sample*Group MSG Control MSG Dialysis -13.2365 7.0072 401 -1.89 0.0596 
Sample*Group NaCl Control NaCl Dialysis -12.1924 7.0046 401 -1.74 0.0825 
Sample*Group NaPO4 Control NaPO4 Dialysis -3.7394 7.0087 400 -0.53 0.5940 
Sample*Group Urea Control Urea Dialysis 6.0835 7.0013 402 0.87 0.3854 
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Liking Unadjusted ratings 516 
 517 
Least Squares Means 
Effect Sample Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control 34.3014 2.2049 93.9 15.56 <.0001 
Group   Dialysis 30.4141 3.1490 94.4 9.66 <.0001 
Sample*Group CaCl Control 14.7844 3.8895 409 3.80 0.0002 
Sample*Group CaCl Dialysis 7.3999 5.2444 386 1.41 0.1590 
Sample*Group FeSO4 Control 26.9180 3.9907 396 6.75 <.0001 
Sample*Group FeSO4 Dialysis 30.9796 5.3675 374 5.77 <.0001 
Sample*Group First Control 21.2500 3.9907 396 5.32 <.0001 
Sample*Group First Dialysis 20.9210 5.3676 374 3.90 0.0001 
Sample*Group H3PO4 Control 39.4327 3.8894 409 10.14 <.0001 
Sample*Group H3PO4 Dialysis 27.4197 5.2442 386 5.23 <.0001 
Sample*Group KCl Control 28.6136 3.8895 409 7.36 <.0001 
Sample*Group KCl Dialysis 30.3835 5.2398 387 5.80 <.0001 
Sample*Group MSG Control 36.2537 3.8862 410 9.33 <.0001 
Sample*Group MSG Dialysis 31.7734 5.2426 386 6.06 <.0001 
Sample*Group NaCl Control 34.9941 3.8895 409 9.00 <.0001 
Sample*Group NaCl Dialysis 30.8173 5.2351 388 5.89 <.0001 
Sample*Group NaPO4 Control 55.1876 3.8895 409 14.19 <.0001 
Sample*Group NaPO4 Dialysis 52.8365 5.2427 386 10.08 <.0001 
Sample*Group Urea Control 24.1239 3.8900 409 6.20 <.0001 
Sample*Group Urea Dialysis 16.2154 5.2280 390 3.10 0.0021 
Sample*Group Water Control 61.4560 3.8865 410 15.81 <.0001 





Type 3 Tests of Fixed Effects  
Effect Num DF Den DF F Value Pr > F  
Sample 9 343 28.12 <.0001  
Group 1 95 0.78 0.3794  
Sex 1 97.5 0.01 0.9423  
YOB 1 97.5 0.00 0.9626  
Sample*Group 9 343 0.72 0.6940  
 522 
 523 
Differences of Least Squares Means 
Effect Sample Group _Sample _Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control   Dialysis 3.8873 4.4018 95 0.88 0.3794 
Sample*Group CaCl Control CaCl Dialysis 7.3844 6.8725 355 1.07 0.2833 
Sample*Group FeSO4 Control FeSO4 Dialysis -4.0616 7.0238 344 -0.58 0.5635 
Sample*Group First Control First Dialysis 0.3290 7.0239 344 0.05 0.9627 
Sample*Group H3PO4 Control H3PO4 Dialysis 12.0130 6.8721 355 1.75 0.0813 
Sample*Group KCl Control KCl Dialysis -1.7699 6.8689 356 -0.26 0.7968 
Sample*Group MSG Control MSG Dialysis 4.4803 6.8691 356 0.65 0.5147 
Sample*Group NaCl Control NaCl Dialysis 4.1768 6.8654 357 0.61 0.5433 
Sample*Group NaPO4 Control NaPO4 Dialysis 2.3511 6.8712 355 0.34 0.7324 
Sample*Group Urea Control Urea Dialysis 7.9085 6.8602 358 1.15 0.2498 
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Flavor adjusted for water rating 532 
 533 
Least Squares Means 
Effect Sample Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control 29.8934 3.0605 76 9.77 <.0001 
Group   Dialysis 42.3710 4.3675 76.4 9.70 <.0001 
Sample*Group CaCl Control 58.7834 4.5965 282 12.79 <.0001 
Sample*Group CaCl Dialysis 71.7251 6.3080 258 11.37 <.0001 
Sample*Group FeSO4 Control 30.9222 4.7210 298 6.55 <.0001 
Sample*Group FeSO4 Dialysis 43.8567 6.3994 270 6.85 <.0001 
Sample*Group First Control 52.0630 4.7206 298 11.03 <.0001 
Sample*Group First Dialysis 37.5424 6.3816 271 5.88 <.0001 
Sample*Group H3PO4 Control 34.5357 4.6018 284 7.50 <.0001 
Sample*Group H3PO4 Dialysis 43.1431 6.2871 257 6.86 <.0001 
Sample*Group KCl Control 24.1049 4.6039 285 5.24 <.0001 
Sample*Group KCl Dialysis 37.0968 6.2610 255 5.93 <.0001 
Sample*Group MSG Control 8.7732 4.5852 287 1.91 0.0567 
Sample*Group MSG Dialysis 35.3913 6.2643 259 5.65 <.0001 
Sample*Group NaCl Control 34.2395 4.6024 282 7.44 <.0001 
Sample*Group NaCl Dialysis 60.5436 6.2646 257 9.66 <.0001 
Sample*Group NaPO4 Control -9.6758 4.6100 284 -2.10 0.0367 
Sample*Group NaPO4 Dialysis 10.4004 6.2775 256 1.66 0.0988 
Sample*Group Urea Control 35.2947 4.6043 284 7.67 <.0001 
Sample*Group Urea Dialysis 41.6400 6.2119 259 6.70 <.0001 
 534 
Type 3 Tests of Fixed Effects  
Effect Num DF Den DF F Value Pr > F  
Sample 8 296 38.40 <.0001  
Group 1 76.8 4.18 0.0443 See below 
Sex 1 78.7 1.98 0.1636  
YOB 1 78.7 15.02 0.0002 0.5685 +/- 0.1467 





Differences of Least Squares Means 
Effect Sample Group _Sample _Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control   Dialysis -12.4776 6.1024 76.8 -2.04 0.0443 
Sample*Group CaCl Control CaCl Dialysis -12.9416 8.3506 227 -1.55 0.1226 
Sample*Group FeSO4 Control FeSO4 Dialysis -12.9345 8.4852 238 -1.52 0.1287 
Sample*Group First Control First Dialysis 14.5206 8.4729 239 1.71 0.0879 
Sample*Group H3PO4 Control H3PO4 Dialysis -8.6074 8.3379 227 -1.03 0.3030 
Sample*Group KCl Control KCl Dialysis -12.9919 8.3199 226 -1.56 0.1198 
Sample*Group MSG Control MSG Dialysis -26.6181 8.3112 228 -3.20 0.0016 
Sample*Group NaCl Control NaCl Dialysis -26.3041 8.3136 226 -3.16 0.0018 
Sample*Group NaPO4 Control NaPO4 Dialysis -20.0762 8.3413 227 -2.41 0.0169 
Sample*Group Urea Control Urea Dialysis -6.3453 8.2794 227 -0.77 0.4442 
 539 
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Liking ratings adjusted for water 542 
 543 
Least Squares Means 
Effect Sample Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control -34.3982 3.6389 64.5 -9.45 <.0001 
Group   Dialysis -17.5703 5.1894 64.8 -3.39 0.0012 
Sample*Group CaCl Control -50.0028 4.8227 178 -10.37 <.0001 
Sample*Group CaCl Dialysis -37.1318 6.6786 163 -5.56 <.0001 
Sample*Group FeSO4 Control -37.9895 4.9022 206 -7.75 <.0001 
Sample*Group FeSO4 Dialysis -14.1806 6.7215 181 -2.11 0.0363 
Sample*Group First Control -46.1758 4.9018 206 -9.42 <.0001 
Sample*Group First Dialysis -24.8966 6.7026 181 -3.71 0.0003 
Sample*Group H3PO4 Control -25.8989 4.8243 180 -5.37 <.0001 
Sample*Group H3PO4 Dialysis -18.3216 6.6612 161 -2.75 0.0066 
Sample*Group KCl Control -37.3160 4.8245 180 -7.73 <.0001 
Sample*Group KCl Dialysis -15.2039 6.6388 160 -2.29 0.0233 
Sample*Group MSG Control -29.3898 4.8039 180 -6.12 <.0001 
Sample*Group MSG Dialysis -15.0603 6.6339 161 -2.27 0.0245 
Sample*Group NaCl Control -30.7353 4.8284 178 -6.37 <.0001 
Sample*Group NaCl Dialysis -12.7240 6.6366 161 -1.92 0.0570 
Sample*Group NaPO4 Control -10.6184 4.8332 180 -2.20 0.0293 
Sample*Group NaPO4 Dialysis 7.7008 6.6521 161 1.16 0.2487 
Sample*Group Urea Control -41.4573 4.8277 179 -8.59 <.0001 
Sample*Group Urea Dialysis -28.3149 6.5822 160 -4.30 <.0001 
 544 
Type 3 Tests of Fixed Effects  
Effect Num DF Den DF F Value Pr > F  
Sample 8 296 20.34 <.0001  
Group 1 65 5.39 0.0234 See below 
Sex 1 66.1 0.10 0.7543  
YOB 1 66.1 5.02 0.0284 0.3893 +/- 0.1738 
Sample*Group 8 296 0.88 0.5326 Ignore this, and see below (we 
don’t care about all the possible 
comparisons, which this value is 
using) 
 545 
Differences of Least Squares Means 
Effect Sample Group _Sample _Group Estimate Standard 
Error 
DF t Value Pr > |t| 
Group   Control   Dialysis -16.8279 7.2466 65 -2.32 0.0234 
Sample*Group CaCl Control CaCl Dialysis -12.8710 8.9565 143 -1.44 0.1529 
Sample*Group FeSO4 Control FeSO4 Dialysis -23.8088 9.0286 158 -2.64 0.0092 
Sample*Group First Control First Dialysis -21.2793 9.0156 158 -2.36 0.0195 
Sample*Group H3PO4 Control H3PO4 Dialysis -7.5773 8.9445 143 -0.85 0.3983 
Sample*Group KCl Control KCl Dialysis -22.1121 8.9283 142 -2.48 0.0144 
Sample*Group MSG Control MSG Dialysis -14.3295 8.9128 143 -1.61 0.1101 
Sample*Group NaCl Control NaCl Dialysis -18.0113 8.9226 142 -2.02 0.0454 
Sample*Group NaPO4 Control NaPO4 Dialysis -18.3192 8.9469 143 -2.05 0.0424 
Sample*Group Urea Control Urea Dialysis -13.1423 8.8851 141 -1.48 0.1413 
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